Medidata Detect, a NYC-based provider of a comprehensive data surveillance and risk monitoring solution that improves data quality and promotes patient safety in clinical trials, received an investment from TFS HealthScience.
The amount of the deal was not disclosed.
This partnership solidifies TFS as a clinical research organization focused on accelerating safety review cycles and helping biotechnology and pharmaceutical companies bring products, therapies, and medications to market.
Led by Chief Executive Officer Dr. Bassem Saleh, and Chief Technology Officer Tom Doyle, Medidata Detect is focused on to help data managers and clinical operations teams to improve patient safety, data quality oversight, and risk management. By analyzing and harmonizing data from many sources in a single location and identifying patterns and discrepancies, this solution offers a complete view of clinical trials and drives efficient workflows.